Givat Hen, Israel—Exciting news from Israel last week. New research from an Israeli study examining the effectiveness of a CBD and cannabis terpene formulation produced “highly positive” initial results. The study focused on finding a treatment for “a diverse range of inflammatory conditions, including the life-threatening cytokine storm syndrome caused by COVID-19.”
Researchers combined CBD with a terpene formulation from Eybna, an Israeli terpene company.
“The early results from the study show that the terpene formulation combined with CBD is twice as effective than CBD alone, and a common corticosteroids treatment for inflammation, Dexamethasone. The developers of the formulation say the results show that terpenes play an important medical role and are not just for flavour and fragrance.”
According to the researchers, “this is opening a new world for synergistically-effective natural formulations” a.k.a the “entourage effect” found in full-spectrum hemp products.
This just goes to show that when whole plant, “full-spectrum” supplements or medicines are taken the effects are significantly more positive – twice as effective, according to this study, to be exact.
Interested in adding some full-spectrum Hemp (CBD+terpenes+other good cannabinoids, fats, lipids, phytonutrients) to your health regimen? Go to our shop to check out our line of full-spectrum, 100% bioactive hemp-derived CBD products.
